Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biapenem vs meropenem for acute lower respiratory tract bacterial infection
CTR20132602Phase 2Completed
- Sponsor
- Furikangzheng Medical Technology
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of biapenem in acute lower respiratory tract infection (LRTI), community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), chronic obstructive pulmonary disease (COPD), bronchiectasis, sponsored by Furikangzheng Medical Technology. Started Mar 2014; status: completed.
02
Drugs
biapenem
03
Conditions
acute lower respiratory tract infection (LRTI)community-acquired pneumonia (CAP)hospital-acquired pneumonia (HAP)chronic obstructive pulmonary disease (COPD)bronchiectasis
Beyond the preview
Go deeper on CTR20132602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132602.